Previous close | 18.50 |
Open | 18.50 |
Bid | 18.50 x 30000 |
Ask | 19.20 x 30000 |
Day's range | 18.50 - 18.70 |
52-week range | 11.39 - 21.00 |
Volume | |
Avg. volume | 68 |
Market cap | 17.355B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.16 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 12 May 2022 |
1y target est | 60.83 |
(Bloomberg) -- Royal Philips NV may have to deal with the consequences of a costly recall of sleep apnea devices for another seven years, according to its chief executive officer.Most Read from BloombergPakistan Rupee Set to Become Top Performing Currency Globally Europe’s Richest Royal Family Builds $300 Billion Finance EmpireTop Chinese Scientist Claims India Moon Landing Nowhere Near South PoleDianne Feinstein, Longest-Serving Female Senator, Dies at 90UAW Aims For At Least 30% Wage Bump to W
We have narrowed our search to three value stocks from the Medical sector. These are PHG, RDNT and BVS.
Prestige Consumer (PBH) benefits from a robust healthcare brand portfolio and solid demand.